A First in Man Study of MABp1 in Patients With Advanced Cancers

NCT01021072 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancers

Interventions

DRUG: MABp1

Sponsor

Janssen Research & Development, LLC